The role of glyoxalases for sugar stress and aging, with relevance for dyskinesia, anxiety, dementia and Parkinson's disease

Aging

Volumn 3, Issue 1, 2011, Pages 5-9

  Auburger, Georg ^a   Kurz, Alexander ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOYLGLUTATHIONE LYASE;

AGING; ANIMAL; ANXIETY; CARBOHYDRATE METABOLISM; DEMENTIA; DYSKINESIA; GENETICS; HUMAN; METABOLISM; NOTE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

AGING; ANIMALS; ANXIETY; CARBOHYDRATE METABOLISM; DEMENTIA; DYSKINESIAS; HUMANS; LACTOYLGLUTATHIONE LYASE; PARKINSON DISEASE; STRESS, PHYSIOLOGICAL;

EID: 79958249456     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100258     Document Type: Note

References (67)

1. Magistretti PJ. Neuron-glia metabolic coupling and plasticity. J Exp Biol 2006; 209:2304-2311.
2. Lutz PL, Nilsson GE. Contrasting strategies for anoxic brain survival-glycolysis up or down. J Exp Biol 1997; 200:411-419.
3. Hipkiss AR. Mitochondrial dysfunction, proteotoxicity, and aging: causes or effects, and the possible impact of NAD+- controlled protein glycation. Adv Clin Chem 2010; 50:123-150.
4. Fleming TH, Humpert PM, Nawroth PP, Bierhaus A. Reactive Metabolites and AGE/RAGE-Mediated Cellular Dysfunction Affect the Aging Process - A Mini-Review. Gerontology 2010 [Epub ahead of print].
5. Rabbani N, Thornalley PJ. Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress. Biochem Soc Trans 2008; 36:1045-1050.
6. Bento CF, Marques F, Fernandes R, Pereira P. Methylglyoxal alters the function and stability of critical components of the protein quality control. PLoS One 2010; 5:e13007.
7. Ferguson GP, Totemeyer S, MacLean MJ, Booth IR. Methylglyoxal production in bacteria: suicide or survival? Arch Microbiol 1998; 170:209-218.
8. Ozyamak E, Black SS, Walker CA, Maclean MJ, Bartlett W, Miller S, Booth IR. The critical role of S-lactoylglutathione formation during methylglyoxal detoxification in Escherichia coli. Mol Microbiol 2010; 78:1577-1590.
9. Maeta K, Izawa S, Inoue Y. Methylglyoxal, a metabolite derived from glycolysis, functions as a signal initiator of the high osmolarity glycerol-mitogen-activated protein kinase cascade and calcineurin/Crz1-mediated pathway in Saccharomyces cerevisiae. J Biol Chem 2005; 280:253-260.
10. Thornalley PJ. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol 1996; 27:565-573.
11. Creighton DJ, Zheng ZB, Holewinski R, Hamilton DS, Eiseman JL. Glyoxalase I inhibitors in cancer chemotherapy. Biochem Soc Trans 2003; 31:1378-1382.
12. Bento CF, Fernandes R, Ramalho J, Marques C, Shang F, Taylor A, Pereira P. The chaperone-dependent ubiquitin ligase CHIP targets HIF-1alpha for degradation in the presence of methylglyoxal. PLoS One 2010; 5:e15062.
13. Hambsch B, Chen BG, Brenndorfer J, Meyer M, Avrabos C, Maccarrone G, Liu RH, Eder M, Turck CW, Landgraf R. Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain. J Neurochem 2010; 113:1240-1251.
14. Weber YG, Storch A, Wuttke TV, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C, Schneider SA, Huber SM and others. GLUT1 mutations are a cause of paroxysmal exertioninduced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008; 118:2157-2168.
15. Lee HY, Xu Y, Huang Y, Ahn AH, Auburger GW, Pandolfo M, Kwiecinski H, Grimes DA, Lang AE, Nielsen JE et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004; 13:3161-3170.
16. Zhu MM, Skraly FA, Cameron DC. Accumulation of methylglyoxal in anaerobically grown Escherichia coli and its detoxification by expression of the Pseudomonas putida glyoxalase I gene. Metab Eng 2001; 3:218-225.
17. Chauhan SC, Madhubala R. Glyoxalase I gene deletion mutants of Leishmania donovani exhibit reduced methylglyoxal detoxification. PLoS One 2009; 4:e6805.
18. Ispolnov K, Gomes RA, Silva MS, Freire AP. Extracellular methylglyoxal toxicity in Saccharomyces cerevisiae: role of glucose and phosphate ions. J Appl Microbiol 2008; 104:1092- 1102.
19. Singla-Pareek SL, Reddy MK, Sopory SK. Genetic engineering of the glyoxalase pathway in tobacco leads to enhanced salinity tolerance. Proc Natl Acad Sci U S A 2003; 100:14672-14677.
20. Singla-Pareek SL, Yadav SK, Pareek A, Reddy MK, Sopory SK. Transgenic tobacco overexpressing glyoxalase pathway enzymes grow and set viable seeds in zinc-spiked soils. Plant Physiol 2006; 140:613-623.
21. Morcos M, Du X, Pfisterer F, Hutter H, Sayed AA, Thornalley P, Ahmed N, Baynes J, Thorpe S, Kukudov G and others. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 2008; 7:260-269.
22. Miller AG, Smith DG, Bhat M, Nagaraj RH. Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J Biol Chem 2006; 281:11864-11871.
23. Brouwers O, Niessen PM, Ferreira I, Miyata T, Scheffer PG, Teerlink T, Schrauwen P, Brownlee M, Stehouwer CD, Schalkwijk CG. Overexpression of Glyoxalase-I Reduces Hyperglycemiainduced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats. J Biol Chem 2011; 286:1374-1380.
24. Wilkins JC, Homer KA, Beighton D. Analysis of Streptococcus mutans proteins modulated by culture under acidic conditions. Appl Environ Microbiol 2002; 68:2382-2390.
25. Korithoski B, Levesque CM, Cvitkovitch DG. Involvement of the detoxifying enzyme lactoylglutathione lyase in Streptococcus mutans aciduricity. J Bacteriol 2007; 189:7586-92.
26. Passalacqua KD, Bergman NH, Lee JY, Sherman DH, Hanna PC. The global transcriptional responses of Bacillus anthracis Sterne (34F2) and a Delta sodA1 mutant to paraquat reveal metal ion homeostasis imbalances during endogenous superoxide stress. J Bacteriol 2007; 189:3996-4013.
27. Wang Y, Cao YY, Jia XM, Cao YB, Gao PH, Fu XP, Ying K, Chen WS, Jiang YY. Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radic Biol Med 2006; 40:1201-1209.
28. Sommer A, Fischer P, Krause K, Boettcher K, Brophy PM, Walter RD, Liebau E. A stress-responsive glyoxalase I from the parasitic nematode Onchocerca volvulus. Biochem J 2001; 353:445-452.
29. Mustafiz A, Singh AK, Pareek A, Sopory SK, Singla-Pareek SL. Genome-wide analysis of rice and Arabidopsis identifies two glyoxalase genes that are highly expressed in abiotic stresses. Funct Integr Genomics 2010 [Epub ahead of print].
30. Goggin DE, Powles SB, Steadman KJ. Selection for low or high primary dormancy in Lolium rigidum Gaud seeds results in constitutive differences in stress protein expression and peroxidase activity. J Exp Bot 2010 [Epub ahead of print].
31. Lee DG, Ahsan N, Lee SH, Lee JJ, Bahk JD, Kang KY, Lee BH. Chilling stress-induced proteomic changes in rice roots. J Plant Physiol 2009; 166:1-11.
32. Du H, Liang Y, Pei K, Ma K. UV Radiation Responsive Proteins in Rice Leaves: a Proteomic Analysiss. Plant Cell Physiol 2010 [Epub ahead of print].
33. Veena, Reddy VS, Sopory SK. Glyoxalase I from Brassica juncea: molecular cloning, regulation and its over-expression confer tolerance in transgenic tobacco under stress. Plant J 1999; 17:385-395.
34. Sun W, Xu X, Zhu H, Liu A, Liu L, Li J, Hua X. Comparative transcriptomic profiling of a salt-tolerant wild tomato species and a salt-sensitive tomato cultivar. Plant Cell Physiol 2010; 51:997-1006.
35. Ranganathan S, Walsh ES, Tew KD. Glyoxalase I in detoxification: studies using a glyoxalase I transfectant cell line. Biochem J 1995; 309:127-131.
36. Scheckhuber CQ, Mack SJ, Strobel I, Ricciardi F, Gispert S, Osiewacz HD. Modulation of the glyoxalase system in the aging model Podospora anserina: effects on growth and lifespan. Aging 2010; 2:969-980.
37. Scheckhuber CQ, Osiewacz HD. Podospora anserina: a model organism to study mechanisms of healthy ageing. Mol Genet Genomics 2008; 280:365-374.
38. Borghouts C, Werner A, Elthon T, Osiewacz HD. Coppermodulated gene expression and senescence in the filamentous fungus Podospora anserina. Mol Cell Biol 2001; 21:390-399.
39. Scheckhuber CQ, Erjavec N, Tinazli A, Hamann A, Nystrom T, Osiewacz HD. Reducing mitochondrial fission results in increased life span and fitness of two fungal ageing models. Nat Cell Biol 2007; 9:99-105.
40. Luce K, Osiewacz HD. Increasing organismal healthspan by enhancing mitochondrial protein quality control. Nat Cell Biol 2009; 11:852-858.
41. Kunstmann B, Osiewacz HD. Over-expression of an Sadenosylmethionine- dependent methyltransferase leads to an extended lifespan of Podospora anserina without impairments in vital functions. Aging Cell 2008; 7:651-662.
42. Kunstmann B, Osiewacz HD. The S-adenosylmethionine dependent O-methyltransferase PaMTH1: a longevity assurance factor protecting Podospora anserina against oxidative stress. Aging 2009; 1:328-334.
43. Ranganathan S, Ciaccio PJ, Walsh ES, Tew KD. Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation. Gene 1999; 240:149-155.
44. Kuhla B, Boeck K, Luth HJ, Schmidt A, Weigle B, Schmitz M, Ogunlade V, Munch G, Arendt T. Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging 2006; 27:815-822.
45. Piec I, Listrat A, Alliot J, Chambon C, Taylor RG, Bechet D. Differential proteome analysis of aging in rat skeletal muscle. Faseb J 2005; 19:1143-1145.
46. Kromer SA, Kessler MS, Milfay D, Birg IN, Bunck M, Czibere L, Panhuysen M, Putz B, Deussing JM, Holsboer F and others. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 2005; 25:4375- 4384.
47. Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM, Ellison JA, Schadt EE, Verma IM, Lockhart DJ and others. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005; 438:662-666.
48. Ditzen C, Jastorff AM, Kessler MS, Bunck M, Teplytska L, Erhardt A, Kromer SA, Varadarajulu J, Targosz BS, Sayan-Ayata EF and others. Protein biomarkers in a mouse model of extremes in trait anxiety. Mol Cell Proteomics 2006; 5:1914-1920.
49. Williams Rt, Lim JE, Harr B, Wing C, Walters R, Distler MG, Teschke M, Wu C, Wiltshire T, Su AI and others. A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS One 2009; 4:e4649.
50. Fujimoto M, Uchida S, Watanuki T, Wakabayashi Y, Otsuki K, Matsubara T, Suetsugi M, Funato H, Watanabe Y. Reduced expression of glyoxalase-1 mRNA in mood disorder patients. Neurosci Lett 2008; 438:196-199.
51. Arai M, Yuzawa H, Nohara I, Ohnishi T, Obata N, Iwayama Y, Haga S, Toyota T, Ujike H, Arai M and others. Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch Gen Psychiatry 2010; 67:589-597.
52. Junaid MA, Kowal D, Barua M, Pullarkat PS, Sklower Brooks S, Pullarkat RK. Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A 2004; 131:11-17.
53. Chen F, Wollmer MA, Hoerndli F, Munch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Gotz J. Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A 2004; 101:7687- 7692.
54. Kuhla B, Boeck K, Schmidt A, Ogunlade V, Arendt T, Munch G, Luth HJ. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging 2007; 28:29-41.
55. Guix FX, Ill-Raga G, Bravo R, Nakaya T, de Fabritiis G, Coma M, Miscione GP, Villa-Freixa J, Suzuki T, Fernandez-Busquets X and others. Amyloid-dependent triose-phosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Brain 2009; 132:1335-1345.
56. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG and others. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41:1308-1312.
57. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003; 300:636- 640.
58. Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alphasynuclein mutation. Exp Neurol 2004; 187:279-288.
59. Kurz A, Rabbani N, Walter M, Bonin M, Thornalley P, Auburger G, Gispert S. Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. Cell Mol Life Sci 2010 [Epub ahead of print].
60. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 2004; 279:18614- 18622.
61. Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AH and others. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 1994; 35:38-44.
62. Munch G, Luth HJ, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P. Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation? J Chem Neuroanat 2000; 20:253-257.
63. Wu L, Eftekharpour E, Davies GF, Roesler WJ, Juurlink BH. Troglitazone selectively inhibits glyoxalase I gene expression. Diabetologia 2001; 44:2004-2012.
64. Johansson AS, Ridderstrom M, Mannervik B. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I. Mol Pharmacol 2000; 57:619-624.
65. Dukic-Stefanovic S, Schinzel R, Riederer P, Munch G. AGES in brain ageing: AGE-inhibitors as neuroprotective and antidementia drugs? Biogerontology 2001; 2:19-34.
66. de Arriba SG, Stuchbury G, Yarin J, Burnell J, Loske C, Munch G. Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells--protection by carbonyl scavengers. Neurobiol Aging 2007; 28:1044-1050.
67. Hipkiss AR. Aging, Proteotoxicity, Mitochondria, Glycation, NAD and Carnosine: Possible Inter-Relationships and Resolution of the Oxygen Paradox. Front Front Aging Neurosci 2010; 2:10.